Training in Gender Affirming Care is Medically Necessary

References

1. 1.↵
   Senate Bill 150: An Act Relating to Children (2023).
2. 2.↵
   Mallory CaER. The Impact of 2023 Legislation on Transgender Youth. 2023. Accessed 5/15/24. Available at: https://williamsinstitute.law.ucla.edu/wp-content/uploads/Trans-Legislation-Summary-Oct-2023.pdf.
3. 3.↵
   1. Barr WF,
   2. Peterson LE

   . Residents’ intention to provide gender affirming care. J Am Board Fam Med 2024.
4. 4.↵
   1. Dahlgren Allen S,
   2. Tollit MA,
   3. McDougall R,
   4. Eade D,
   5. Hoq M,
   6. Pang KC

   . A waitlist intervention for transgender young people and psychosocial outcomes. Pediatrics 2021;148.
5. 5.↵
   1. Aldridge Z,
   2. Patel S,
   3. Guo B,
   4. et al

   . Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: a prospective cohort study. Andrology 2021;9:1808–16.

   OpenUrlPubMed
6. 6.↵
   1. Rowniak S,
   2. Bolt L,
   3. Sharifi C

   . Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review. JBI Database System Rev Implement Rep 2019;17:1826–54.

   OpenUrlPubMed
7. 7.↵
   1. Tordoff DM,
   2. Wanta JW,
   3. Collin A,
   4. Stepney C,
   5. Inwards-Breland DJ,
   6. Ahrens K

   . Mental health outcomes in transgender and nonbinary youths receiving gender-affirming care. JAMA Netw Open 2022;5:e220978.

   OpenUrlCrossRef
8. 8.↵
   1. Puckett JA,
   2. Cleary P,
   3. Rossman K,
   4. Newcomb ME,
   5. Mustanski B

   . Barriers to gender-affirming care for transgender and gender nonconforming individuals. Sex Res Social Policy 2018;15:48–59.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Almazan AN,
   2. Keuroghlian AS

   . Association between gender-affirming surgeries and mental health outcomes. JAMA Surg 2021;156:611–8.

   OpenUrlPubMed
10. 10.↵
    1. Roberts CM,
    2. Klein DA,
    3. Adirim TA,
    4. Schvey NA,
    5. Hisle-Gorman E

    . Continuation of gender-affirming hormones among transgender adolescents and adults. J Clin Endocrinol Metab 2022;107:e3937–e3943.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. van der Loos M,
    2. Hannema SE,
    3. Klink DT,
    4. den Heijer M,
    5. Wiepjes CM

    . Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands. Lancet Child Adolesc Health 2022;6:869–75.

    OpenUrlPubMed
12. 12.↵
    1. Dubin SN,
    2. Nolan IT,
    3. Streed CG Jr.,
    4. Greene RE,
    5. Radix AE,
    6. Morrison SD

    . Transgender health care: improving medical students' and residents' training and awareness. Adv Med Educ Pract 2018;9:377–91.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. van Heesewijk J,
    2. Kent A,
    3. van de Grift TC,
    4. Harleman A,
    5. Muntinga M

    . Transgender health content in medical education: a theory-guided systematic review of current training practices and implementation barriers & facilitators. Adv Health Sci Educ Theory Pract 2022;27:817–46.

    OpenUrlPubMed